抗环瓜氨酸肽抗体作为抗合成酶综合征中侵蚀性关节炎的标志物。 - Suppr

Suppr

超能文献

Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.

作者信息

Cavagna Lorenzo, Fusetti Chiara, Montecucco Carlomaurizio, Caporali Roberto

出版信息

J Rheumatol. 2010 Sep;37(9):1967; author reply 1968. doi: 10.3899/jrheum.091402.

DOI:10.3899/jrheum.091402

PMID:20810525

Abstract

摘要

相似文献

Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.

J Rheumatol. 2010 Sep;37(9):1967; author reply 1968. doi: 10.3899/jrheum.091402.

Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.

J Rheumatol. 2004 May;31(5):1012-3; author reply 1013.

Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies.

J Rheumatol. 2009 Sep;36(9):2133-4. doi: 10.3899/jrheum.090183.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.

The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.

Lupus. 2009 Jul;18(8):713-7. doi: 10.1177/0961203309102817.

Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.

J Rheumatol. 2009 Apr;36(4):663-4. doi: 10.3899/jrheum.090184.

[Jo-1-(antisynthetase-) syndrome--do autoantibodies improve classification of myositis?].

Z Rheumatol. 1993 Sep-Oct;52(5):259-63.

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

Arthritis Res Ther. 2005;7(3):R592-603. doi: 10.1186/ar1719. Epub 2005 Mar 17.

Antisynthetase syndrome without myositis secondary to AA amyloidosis: a non-described association.

Nefrologia. 2011;31(1):117-9. doi: 10.3265/Nefrologia.pre2010.Sep.10469.

[Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].

Rev Med Suisse. 2005 Mar 9;1(10):674, 677-8, 680 passim.

引用本文的文献

Defining anti-synthetase syndrome: a systematic literature review.

Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25.

[Diffuse interstitial lung disease revealing anti-synthetase syndrome: about two cases].

Pan Afr Med J. 2019 Jan 22;32:40. doi: 10.11604/pamj.2019.32.40.17903. eCollection 2019.

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome.

Clin Rheumatol. 2019 May;38(5):1477-1483. doi: 10.1007/s10067-019-04471-y. Epub 2019 Feb 27.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome.

Medicine (Baltimore). 2015 May;94(20):e523. doi: 10.1097/MD.0000000000000523.

New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.

ScientificWorldJournal. 2014 Jan 29;2014:179180. doi: 10.1155/2014/179180. eCollection 2014.

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Biomed Res Int. 2013;2013:759760. doi: 10.1155/2013/759760. Epub 2013 Sep 25.

Clinical heterogeneity and outcomes of antisynthetase syndrome.

Curr Rheumatol Rep. 2013 Aug;15(8):349. doi: 10.1007/s11926-013-0349-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.

作者信息

Cavagna Lorenzo, Fusetti Chiara, Montecucco Carlomaurizio, Caporali Roberto

出版信息

J Rheumatol. 2010 Sep;37(9):1967; author reply 1968. doi: 10.3899/jrheum.091402.

DOI:10.3899/jrheum.091402

PMID:20810525

Abstract

摘要

相似文献

Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.

J Rheumatol. 2010 Sep;37(9):1967; author reply 1968. doi: 10.3899/jrheum.091402.

Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.

J Rheumatol. 2004 May;31(5):1012-3; author reply 1013.

Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies.

J Rheumatol. 2009 Sep;36(9):2133-4. doi: 10.3899/jrheum.090183.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.

The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.

Lupus. 2009 Jul;18(8):713-7. doi: 10.1177/0961203309102817.

Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.

J Rheumatol. 2009 Apr;36(4):663-4. doi: 10.3899/jrheum.090184.

[Jo-1-(antisynthetase-) syndrome--do autoantibodies improve classification of myositis?].

Z Rheumatol. 1993 Sep-Oct;52(5):259-63.

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

Arthritis Res Ther. 2005;7(3):R592-603. doi: 10.1186/ar1719. Epub 2005 Mar 17.

Antisynthetase syndrome without myositis secondary to AA amyloidosis: a non-described association.

Nefrologia. 2011;31(1):117-9. doi: 10.3265/Nefrologia.pre2010.Sep.10469.

[Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].

Rev Med Suisse. 2005 Mar 9;1(10):674, 677-8, 680 passim.

引用本文的文献

Defining anti-synthetase syndrome: a systematic literature review.

Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25.

[Diffuse interstitial lung disease revealing anti-synthetase syndrome: about two cases].

Pan Afr Med J. 2019 Jan 22;32:40. doi: 10.11604/pamj.2019.32.40.17903. eCollection 2019.

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome.

Clin Rheumatol. 2019 May;38(5):1477-1483. doi: 10.1007/s10067-019-04471-y. Epub 2019 Feb 27.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome.

Medicine (Baltimore). 2015 May;94(20):e523. doi: 10.1097/MD.0000000000000523.

New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.

ScientificWorldJournal. 2014 Jan 29;2014:179180. doi: 10.1155/2014/179180. eCollection 2014.

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Biomed Res Int. 2013;2013:759760. doi: 10.1155/2013/759760. Epub 2013 Sep 25.

Clinical heterogeneity and outcomes of antisynthetase syndrome.

Curr Rheumatol Rep. 2013 Aug;15(8):349. doi: 10.1007/s11926-013-0349-8.